ESSA Pharma Inc. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/36d33c57-97ce-4a67-b161-d36111ad85db/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2024 | $-28.5M | 2023-10-01 – 2024-09-30 | evidence 0001558370-24-016318 |
| FY 2023 | $-26.6M | 2022-10-01 – 2023-09-30 | evidence 0001558370-23-019732 |
| FY 2022 | $-35.1M | 2021-10-01 – 2022-09-30 | evidence 0001558370-22-018570 |
| FY 2021 | $-36.8M | 2020-10-01 – 2021-09-30 | evidence 0001558370-21-016181 |
| FY 2020 | $-23.4M | 2019-10-01 – 2020-09-30 | evidence 0001558370-20-014403 |
| FY 2019 | $-12.8M | 2018-10-01 – 2019-09-30 | evidence 0001558370-20-014403 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).